Key Points
- To describe the pathophysiology of accelerated heart failure deterioration, framing overload-induced myocardial changes as a distinct cardiomyopathy of overload.
- Review of clinical evidence and pathophysiology regarding congestive heart failure and cardiac hypertrophy.
- Evaluation of cellular mechanisms, including myocardial energy starvation, fetal protein expression, and neurohormonal growth pathways.
- Chronic hemodynamic overloading accelerates myocardial failure, reducing the functional lifespan of the heart from 90–100 years to approximately 5 years.
- The deterioration involves myocardial cell enlargement coupled with decreased cell viability, driven by chronic energy starvation and reactivation of fetal isoforms of muscle proteins.
- Inhibition of converting enzymes slows heart failure progression, supporting the role of angiotensin II-stimulated cellular growth in disease pathogenesis.
Structured PICO
PPopulationPatients with congestive heart failure experiencing overload-induced hypertrophy
IInterventionConverting enzyme inhibitors (ACE inhibitors)
This review conceptualizes the progressive deterioration in heart failure as a 'cardiomyopathy of overload' driven by cellular growth abnormalities that may be mitigated by ACE inhibitors.